Marshall Wace North America’s NxStage Medical Inc. NXTM Stock Holding History

Marshall Wace North America’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-184,953	Closed	-$5.29M	–	2094
2018 Q4	$5.29M	Buy	+184,953	New	+$5.25M	0.05%	242
2018 Q3	–	Sell	-80,372	Closed	-$2.24M	–	1603
2018 Q2	$2.24M	Buy	80,372 +64,889	+419%	+$1.74M	0.01%	738
2018 Q1	$385K	Sell	15,483 -492,581	-97%	-$12M	﹤0.01%	1215
2017 Q4	$12.3M	Buy	508,064 +298,041	+142%	+$7.85M	0.07%	329
2017 Q3	$5.88M	Sell	210,023 -234,595	-53%	-$6.26M	0.04%	505
2017 Q2	$11.1M	Buy	+444,618	New	+$11M	0.08%	294

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Marshall Wace North America's NXTM Position: Q1 2019 in Review

Marshall Wace North America sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 184,953 shares — an estimated $5.29M sold.

Marshall Wace North America first reported a position in NXTM in Q2 2017 and held it in 6 quarters. The position peaked at $12.3M in Q4 2017. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

Marshall Wace North America reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
Marshall Wace North America sold 184,953 NxStage Medical Inc. shares in Q1 2019, an estimated $5.29M.
Marshall Wace North America first reported a position in NxStage Medical Inc. in Q2 2017 and held it in 6 quarters.
Marshall Wace North America's NxStage Medical Inc. position peaked at $12.3M in Q4 2017.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Marshall Wace North America's 13F filing for Q1 2019, filed 14 May 2019.